Aurora Cannabis Inc (NASDAQ:ACB) price closed lower on Monday, April 15, dropping -4.85% below its previous close.
A look at the daily price movement shows that the last close reads $6.60. The company’s 5Y monthly beta was ticking 2.93 while its P/E ratio in the trailing 12-month period read 0.69. Taking into account the 52-week price action we note that the stock hit a 52-week high of $11.50 and 52-week low of $2.84. The stock added 117.30% on its value in the past month.
Aurora Cannabis Inc, which has a market valuation of $98.78 million, is expected to release its quarterly earnings report Jun 12, 2024 – Jun 17, 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ACB a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that ACB’s price is at present 20.40% off the SMA20 and 50.59% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 60.49, with weekly volatility standing at 16.72%. The indicator jumps to 19.78% when calculated based on the past 30 days. Aurora Cannabis Inc (NASDAQ:ACB)’s beta value is holding at 2.22, while the average true range (ATR) indicator is currently reading 0.90.
An analysis of the Aurora Cannabis Inc (NASDAQ:ACB) stock in terms of its daily trading volume indicates that the 3-month average is 5.18 million.
Current records show that the company has 34.53M in outstanding shares. The insiders’ percentage holdings are 1.50% of outstanding shares while the percentage share held by institutions stands at 25.69%. But the 31.88% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
